Personalized therapy algorithms for type 2 diabetes: a phenotype-based approach

References

• International Diabetes FederationIDF Diabetes Atlas5th edBrussels, BelgiumInternational Diabetes Federation2011 Available from: http://www.idf.org/diabetesatlasAccessed November 9, 2013
   Google Scholar
• UK Prospective Diabetes Study GroupOverview of 6 years therapy of type 2 diabetes: a progressive diseaseDiabetes19954411124912587589820
   PubMed Web of Science ®Google Scholar
• DeFronzoRABanting lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitusDiabetes200958477379519336687
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study GroupIntensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)Lancet199835291788378539742976
   PubMed Web of Science ®Google Scholar
• HolmanRRPaulSKBethelMAMatthewsDRNeilHA10-year follow-up of intensive glucose control in type 2 diabetesN Engl J Med2008359151577158918784090
   PubMed Web of Science ®Google Scholar
• TahraniAABaileyCJDel PratoSBarnettAHManagement of type 2 diabetes: new and future developments in treatmentLancet2011378978618219721705062
   PubMed Web of Science ®Google Scholar
• NyenweEAJerkinsTWUmpierrezGEKitabchiAEManagement of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetesMetabolism201160112321134520
   PubMed Web of Science ®Google Scholar
• InzucchiSEBergenstalRMBuseJBManagement of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Diabetologia20125561577159622526604
   PubMed Web of Science ®Google Scholar
• TurnerRCCullCAFrighiVHolmanRRGlycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study GroupJAMA1999281212005201210359389
   PubMed Web of Science ®Google Scholar
• RodbardHWJellingerPSDavidsonJAAACE/ACE Consensus Statement American Association of Clinical Endocrinologists/American College of Endocrinology. Consensus Panel on Type 2 Diabetes Mellitus: An Algorithm for Glycemic ControlEndocr Pract200915654055919858063
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical ExcellenceClinical guideline 87 (update of NICE clinical guideline 66). Type 2 diabetes: the management of type 2 diabetes52009 Available from: http://www.nice.org.uk/nicemedia/live/12165/44322/44322.pdfAccessed November 9, 2013
   Google Scholar
• MonnierLLapinskiHColetteCContributions of fasting and postprandial plasma increments to overall diurnal hyperglycaemia of type 2 diabetic patients: variations with increasing levels of HbA1cDiabetes Care200326388188512610053
   PubMed Web of Science ®Google Scholar
• QaseemAHumphreyLLSweetDEStarkeyMShekellePfor the Clinical Guidelines Committee of the American College of PhysiciansOral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of PhysiciansAnn Intern Med2012156321823122312141
   PubMed Web of Science ®Google Scholar
• StoneTTKivlahanCHCoxKREvaluation of physician preferences for guideline implementationAm J Med Qual199914417017710452134
   PubMed Web of Science ®Google Scholar
• KhuntiKDaviesMGlycaemic goals in patients with type 2 diabetes: current status, challenges and recent advancesDiabetes Obes Metab201012647448420518803
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation2012 Clinical Guidelines Task ForceGlobal guideline for type 2 diabetes Available from: http://www.idf.org/global-guideline-type-2-diabetes-2012Accessed November 9, 2013
   Google Scholar
• VirkamäkiASaltevoJFinnish Current Care Guideline for Diabetes: interactive approach to improve individualised treatmentDiabetologia20115451264126521331472
   PubMed Web of Science ®Google Scholar
• Diabetes Treatment Algorithm from the Diabetes Current Care GuidelineWorking group set up by the Finnish Medical Society Duodecim and the Finnish Society of Internal Medicine Available from: http://www.terveysportti.fi/xmedia/ccs/varhainen_diabetes_en.htmlAccessed November 9, 2013
   Google Scholar
• GarberAJAbrahamsonMJBarzilayJIAmerican Association of Clinical EndocrinologistsAACE comprehensive diabetes management algorithm 2013Endocr Pract201319232733623598536
   PubMed Web of Science ®Google Scholar
• SchernthanerGBarnettAHBetteridgeDJIs the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysisDiabetologia20105371258126920352408
   PubMed Web of Science ®Google Scholar
• CerielloAGalloMGentileSGiordaCDe MicheliAon behalf of Associazione Medici DiabetologiTo what extent is the new position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) ‘personalised’?Diabetologia201255102853285522801904
   PubMed Web of Science ®Google Scholar
• Italian Association of Medical DiabetologistsPersonalization of therapy in type 2 diabetes2011 Available from: http://www.aemmedi.it/algoritmi_en_2013/intro-english.htmlAccessed February 18, 2014
   Google Scholar
• RodbardDVigerskyRADesign of a decision support system to help clinicians manage glycemia in patients with type 2 diabetes mellitusJ Diabetes Sci Technol20115240241121527112
   PubMedGoogle Scholar
• Action to Control Cardiovascular Risk in Diabetes Study Group; GersteinHCMillerMEByingtonRPEffects of intensive glucose lowering in type 2 diabetesN Engl J Med2008358242545255918539917
   PubMed Web of Science ®Google Scholar
• ADVANCE Collaborative Group; PatelAMacMahonSChalmersJIntensive blood glucose control and vascular outcomes in patients with type 2 diabetesN Engl J Med2008358242560257218539916
   PubMed Web of Science ®Google Scholar
• DuckworthWAbrairaCMoritzTVADT InvestigatorsGlucose control and vascular complications in veterans with type 2 diabetesN Engl J Med2009360212913919092145
   PubMed Web of Science ®Google Scholar
• BeigiFIMoghissiETiktinMHirschIBInzucchiSEGenuthSIndividualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trialsAnn Intern Med2011154855455921502652
   PubMed Web of Science ®Google Scholar
• SkylerJSBergenstalRBonowROAmerican Diabetes Association; American College of Cardiology Foundation; American Heart Association: Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart AssociationDiabetes Care200932118719219092168
   PubMed Web of Science ®Google Scholar
• EldorRRazIThe individualized target HbA1c: a new method for improving macrovascular risk and glycemia without hypoglycemia and weight gainRev Diabet Stud20096161219557292
   PubMedGoogle Scholar
• RodbardDVigerskyRDevelopment of algorithms for clinical decision support for primary care providersDiabetes Technol Ther200572409
   Google Scholar
• VigerskyRAGalenRSHorneDCavottaMRodbardDComputer assisted decision support (CADS) for primary care of diabetesTelemed E-Health200713168
   Google Scholar
• SmithRJNathanDMArslanianSAGroopLRizzaRARotterJIIndividualizing therapies in type 2 diabetes mellitus based on patient characteristics: what we know and what we need to knowJ Clin Endocrinol Metab20109541566157420194712
   PubMed Web of Science ®Google Scholar
• Del PratoSLaSalleJMatthaeiSBaileyCJGlobal Partnership for Effective Diabetes ManagementTailoring treatment to the individual in type 2 diabetes practical guidance from the Global Partnership for Effective Diabetes ManagementInt J Clin Pract201064329530420456169
   PubMed Web of Science ®Google Scholar
• PozzilliPLeslieRDChanJThe A1C and ABCD of glycaemia management in type 2 diabetes: a physician’s personalized approachDiabetes Metab Res Rev201026423924420503255
   PubMed Web of Science ®Google Scholar
• CerielloAGalloMArmentanoVPerrielloGGentileSDe MicheliAAssociazione Medici DiabetologiPersonalizing treatment in type 2 diabetes: a self-monitoring of blood glucose inclusive innovative approachDiabetes Technol Ther201214437337822216963
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation2011Guideline for management of postmeal glucose in diabetes Available from: http://www.idf.org/sites/default/files/postmeal%20glucose%20guidelines.pdfAccessed November 9, 2013
   Google Scholar
• European Medicines AgencyEuropean public assessment reports Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/landing/epar_search.jsp&mid=WC0b01ac058001d124Accessed November 9, 2013
   Google Scholar
• PolonskyWHFisherLSchikmanCHStructured, self-monitoring blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program studyDiabetes Care201134226226721270183
   PubMed Web of Science ®Google Scholar
• International Diabetes FederationGuideline on self-monitoring of blood glucose in non-insulin treated type 2 diabetes2008 Available from: http://www.idf.org/guidelines/self-monitoringAccessed November 9, 2013
   Google Scholar